Search results
Results from the WOW.Com Content Network
Agoraphobia is believed to be due to a combination of genetic and environmental factors. The condition often runs in families, and stressful or traumatic events such as the death of a parent or being attacked may be a trigger. [1] In the DSM-5, agoraphobia is classified as a phobia along with specific phobias and social phobia.
The Panic and Agoraphobia Scale (PAS) is primarily used for monitoring the efficacy of both medication and psychotherapy treatments of agoraphobia, as well as a screening tool for the disorder. It is available in both self-rated and clinician-rated versions and the scale structure is compatible with DSM-IV and ICD-10 classifications.
Child PTSD Symptom Scale; Clinician Administered PTSD Scale (CAPS) Daily Assessment of Symptoms – Anxiety; Generalized Anxiety Disorder 7 (GAD-7) [4] [5] Hamilton Anxiety Scale (HAM-A) [6] [7] Hospital Anxiety and Depression Scale; Panic and Agoraphobia Scale (PAS) Panic Disorder Severity Scale (PDSS) PTSD Symptom Scale – Self-Report Version
The English suffixes -phobia, -phobic, -phobe (from Greek φόβος phobos, "fear") occur in technical usage in psychiatry to construct words that describe irrational, abnormal, unwarranted, persistent, or disabling fear as a mental disorder (e.g. agoraphobia), in chemistry to describe chemical aversions (e.g. hydrophobic), in biology to describe organisms that dislike certain conditions (e.g ...
The Panic Disorder Severity Scale (PDSS) is a questionnaire developed for measuring the severity of panic disorder. [1] The clinician-administered PDSS is intended to assess severity and considered a reliable tool for monitoring of treatment outcome. [ 2 ]
Mixed anxiety–depressive disorder (MADD) is a diagnostic category that defines patients who have both anxiety and depressive symptoms of limited and equal intensity accompanied by at least some autonomic nervous system features.
The National Comorbidity Survey of over 8,000 American correspondents in 1994 revealed 12-month and lifetime prevalence rates of 7.9 percent and 13.3 percent, respectively; this makes it the third most prevalent psychiatric disorder after depression and alcohol use disorder, and the most common of the anxiety disorders. [199]
Hospital Anxiety and Depression Scale (HADS) was originally developed by Zigmond and Snaith (1983) [1] and is commonly used by doctors to determine the levels of anxiety and depression that a person is experiencing. The HADS is a 14-item scale, with seven items relating to anxiety and seven relating to depression. [2]